Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion

Pediatric Blood and Cancer

Volumn 59, Issue 1, 2012, Pages 194-196

  Dolan, Michelle ^a   Cioc, Adina ^a   Cross, Nicholas C P ^b,c   Neglia, Joseph P ^a   Tolar, Jakub ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b SALISBURY DISTRICT HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

8p11 myeloproliferative syndrome; BCR; BCR FGFR1 gene fusion; FGFR1; Hematopoietic cell transplantation

Indexed keywords

BCR FGFR1 FUSION PROTEIN; CD34 ANTIGEN; CD61 ANTIGEN; HEMOGLOBIN; HEMOGLOBIN F; HYBRID PROTEIN; HYDROXYUREA; UNCLASSIFIED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANEMIA; ARTHRALGIA; ARTICLE; BLAST CELL; CANCER PROGNOSIS; CASE REPORT; CHILD; CHILDHOOD CANCER; CHROMOSOME 8P11 MYELOPROLIFERATIVE SYNDROME; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 22Q11.2; CHROMOSOME TRANSLOCATION 8; CHROMOSOME TRANSLOCATION 8P11.2; DRUG TREATMENT FAILURE; ELECTROPHORESIS; FEVER; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTOSIS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPEROXIDASE STAINING; IMMUNOPHENOTYPING; LEUKOCYTOSIS; MEDICAL HISTORY; MOLECULAR GENETICS; MONOCYTOSIS; MYELOPROLIFERATIVE NEOPLASM; NEUTROPHIL; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SCHOOL CHILD; SHIFT TO THE LEFT; THROMBOCYTOSIS; TREATMENT OUTCOME;

CHILD; CHROMOSOMES, HUMAN, PAIR 22; CHROMOSOMES, HUMAN, PAIR 8; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; PROTO-ONCOGENE PROTEINS C-BCR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSLOCATION, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 84861206616     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23404     Document Type: Article

References (20)

1. Agerstam H, Lilljebjorn H, Lassen C, et al. Fusion gene-mediated truncation of RUNX1 as a potential mechanism underlying disease progression in the 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2007; 46: 635-643.
2. Demiroglu A, Steer EJ, Heath C, et al. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: Transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001; 98: 3778-3783.
3. Murati A, Arnoulet C, Lafage-Pochitaloff M, et al. Dual lympho-myeloproliferative disorder in a patient with t(8;22) with BCR-FGFR1 gene fusion. Int J Oncol 2005; 26: 1485-1492.
4. Pini M, Gottardi E, Scaravaglio P, et al. A fourth case of BCR-FGFR1 positive CML-like disease with t(8;22) translocation showing an extensive deletion on the derivative chromosome 8p. Hematol J 2002; 3: 315-316.
5. Richebourg S, Theisen O. Chronic myeloproliferative disorder with t(8;22)(p11;q11) can mime clonal cytogenetic evolution of authentic chronic myelogenous leukemia. Genes Chromosomes Cancer 2008; 47: 915-918.
6. Roumiantsev S, Krause DS, Neumann CA, et al. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell 2004; 5: 287-298.
7. Swerdlow SH, Campo E, Harris NL, et al. editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC 2008.
8. Abruzzo LV, Jaffe ES, Cotelingam JD, et al. T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 1992; 16: 236-245.
9. Macdonald D, Aguiar RCT, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: A review. Leukemia 1995; 9: 1628-1630.
10. Inhorn RC, Aster JC, Roach SA, et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): Description of a distinctive clinicopathologic entity. Blood 1995; 85: 1881-1887.
11. Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: A review. Hum Pathol 2010; 41: 461-476.
12. Goradia A, Bayerl M, Cornfield D. The 8p11 myeloproliferative syndrome: Review of the literature and an illustrative case report. Int J Clin Exp Pathol 2008; 1: 448-456.
13. Post GR, Holloman D, Christiansen L, et al. Translocation t(3;8;9)(p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: A unique case and review of the literature. Leuk Res 2010; 34: 1543-1544.
14. Macdonald D, Reiter A, Cross NC. The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101-107.
15. Larosa F, Maddens S, Legrand F, et al. Early immune reconstitution and efficient graft vs. tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome. Bone Marrow Transplant 2011; 46: 622-624.
16. Chase A, Grand FH, Cross NCP. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome. Blood 2007; 110: 3729-3734.
17. Wasag B, Lierman E, Meeus P, et al. The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11). Haematologica 2011; 96: 922-926.
18. Chen J, DeAngelo DJ, Kutok JL, et al. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci USA 2004; 101: 14479-14484.
19. Martinez-Climent JA, Vizcarra E, Benet I, et al. Cytogenetic response induced by interferon alpha in the myeloproliferative disorders with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukemia 1998; 12: 999-1000.
20. Zhou L, Fu W, Yuan Z, et al. Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome. Leuk Res 2010; 34: e306-e307.